Rapid Micro Biosystems (RPID) Accumulated Expenses (2020 - 2026)

Rapid Micro Biosystems' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 29.02% year-over-year to $6.5 million; the TTM figure through Mar 2026 stood at $6.5 million (up 29.02% YoY), while the FY2025 annual figure was $8.3 million, up 15.23% from the prior year.
• Accumulated Expenses came in at $6.5 million for Q1 2026 at Rapid Micro Biosystems, down from $8.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $9.9 million in Q4 2023 to a low of $2.3 million in Q2 2022.
• A 5-year average of $6.9 million and a median of $7.0 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses surged 1107.68% in 2022 and declined 28.59% in 2025, its largest moves.
• Rapid Micro Biosystems' Accumulated Expenses stood at $8.2 million in 2022, then gained by 21.56% to $9.9 million in 2023, then slipped by 27.15% to $7.2 million in 2024, then grew by 15.23% to $8.3 million in 2025, then retreated by 21.9% to $6.5 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $6.5 million, $8.3 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison